Sandra L. Fenwick - 18 Nov 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
18 Nov 2022
Net transactions value
$0
Form type
4
Filing time
21 Nov 2022, 15:09:50 UTC
Previous filing
31 May 2022
Next filing
26 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +436 +3.9% 11,634 18 Nov 2022 Direct F1
holding TDOC Common Stock 28,362 18 Nov 2022 By Geoffrey L. Fenwick Family Irrevocable Trust dated 12/17/2020 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -436 -50% $0.000000 436 18 Nov 2022 Common Stock 436 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 The shares are held of record by the Geoffrey L. Fenwick Family Irrevocable Trust for the benefit of the reporting person's children and for which the reporting person and her spouse serve as co-trustees.
F3 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4 The restricted stock units vest in three substantially equal annual installments beginning November 19, 2021.